Vident Advisory’s Amgen AMGN Stock Holding History

Vident Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5M	Buy	37,277 +9,673	+35%	+$3.31M	0.1%	194
2026 Q1	$9.71M	Buy	27,604 +9,252	+50%	+$3.3M	0.08%	209
2025 Q4	$6.01M	Sell	18,352 -1,382	-7%	-$438K	0.05%	284
2025 Q3	$5.57M	Buy	19,734 +1,468	+8%	+$426K	0.05%	277
2025 Q2	$5.1M	Buy	18,266 +417	+2%	+$118K	0.06%	272
2025 Q1	$5.56M	Sell	17,849 -1,482	-8%	-$438K	0.08%	215
2024 Q4	$5.04M	Buy	19,331 +12,250	+173%	+$3.63M	0.09%	209
2024 Q3	$2.28M	Buy	7,081 +1,757	+33%	+$575K	0.06%	352
2024 Q2	$1.66M	Sell	5,324 -110,182	-95%	-$32.4M	0.05%	431
2024 Q1	$32.8M	Buy	115,506 +47,918	+71%	+$14M	0.68%	20
2023 Q4	$19.5M	Sell	67,588 -12,605	-16%	-$3.43M	0.49%	36
2023 Q3	$21.6M	Buy	+80,193	New	+$20M	0.67%	20

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vident Advisory's AMGN Position: Q2 2026 in Review

Vident Advisory increased its Amgen (AMGN) stake by 35% in Q2 2026, buying an estimated $3.31M and bringing the position to 37,277 shares worth $13.5M. The position accounts for 0.1% of the portfolio, ranked #194.

Vident Advisory first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $32.8M in Q1 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Vident Advisory held 37,277 shares of Amgen worth $13.5M as of Q2 2026.
Vident Advisory bought 9,673 Amgen shares in Q2 2026, an estimated $3.31M.
Amgen made up 0.1% of Vident Advisory's portfolio in Q2 2026, its #194 holding.
Vident Advisory first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
Vident Advisory's Amgen position peaked at $32.8M in Q1 2024.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.